The Nordic team published their results in The Journal of Clinical Oncology. They found that the treatment of Hodgkin lymphoma is now so effective that young patients who do not have a relapse within two years of therapy have a life expectancy similar to that of healthy peers. Data from over 2,500 patients were analyzed for this study. The team included researchers from Karolinksa Institutet (Sweden) and colleagues at Aalbord University in Denmark as well as Radiumhospitalet in Oslo, Norway.

Source: News Medical Lifesciences

Pin It on Pinterest